FDA Confirms Recalls of High Blood Pressure, Heart Drugs Over Carcinogens

In several notices, the FDA confirmed recalls of beta blockers carvedilol and metoprolol due to high levels of carcinogenic substances.

A U.S. Food and Drug Administration sign outside the agency's White Oak campus in Silver Spring, Md., on July 17, 2025. Issam Ahmed/AFP via Getty Images

The Food and Drug Administration posted notices on recalls of tens of thousands of bottles of two different types of blood pressure and heart medications, upgrading them to the second-highest classification.

In several recall notices posted between Aug. 12 and Aug. 14, the FDA confirmed the recalls of 88,032 bottles of carvedilol tablets, a drug primarily used to treat high blood pressure, or hypertension, and heart failure.